Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Resource Type
Article
Authors
Lorusso, Domenica ; Xiang, Yang ; Hasegawa, Kosei ; Scambia, Giovanni ; Leiva, Manuel ; Ramos-Elias, Pier ; Acevedo, Alejandro ; Sukhin, Vladyslav ; Cloven, Noelle ; Pereira de Santana Gomes, Andrea J ; Contreras Mejía, Fernando ; Reiss, Ari ; Ayhan, Ali ; Lee, Jung-Yun ; Saevets, Valeriya ; Zagouri, Flora ; Gilbert, Lucy ; Sehouli, Jalid ; Tharavichitkul, Ekkasit ; Lindemann, Kristina ; Lazzari, Roberta ; Chang, Chih-Long ; Lampé, Rudolf ; Zhu, Hong ; Oaknin, Ana ; Christiaens, Melissa ; Polterauer, Stephan ; Usami, Tomoka ; Li, Kan ; Yamada, Karin ; Toker, Sarper ; Keefe, Stephen M ; Pignata, Sandro ; Duska, Linda R
Source
In The Lancet 6-12 April 2024 403(10434):1341-1350
Subject
Primary Research Articles
Language
ISSN
0140-6736